Mark Dornan, based in Toronto, ON, CA, is currently a Director, CMC at Eli Lilly and Company, bringing experience from previous roles at POINT Biopharma, Dana-Farber Cancer Institute and Harvard Medical School. Mark Dornan holds a 2010 - 2015 Doctor of Philosophy (Ph.D.) in Chemistry @ University of Ottawa / Université d'Ottawa. With a robust skill set that includes Chemistry, Medicinal Chemistry and more, Mark Dornan contributes valuable insights to the industry. Mark Dornan has 3 emails and 1 mobile phone number on RocketReach.